Tags : Mesoblast

PharmaShots Weekly Snapshot (Nov 16-20, 2020)

Tuba Khan November 20, 2020

Eli Lilly and Incyte Receive FDA’s EUA for Baricitinib + Remdesivir to Treat Hospitalized Patients with COVID-19 Published: Nov 20,2020 | Tags: baricitinib, COVID-19, Eli Lilly, Emergency Use Authorization, FDA’s, Incyte, receives, Remdesivir Novartis Signs a License Agreement with Mesoblast to Develop and Commercialize Remestemcel-L for ARDS Published: Nov 20,2020 | Tags: Agreement, ARDS, Commercialize, […]Read More

Biotech

Novartis Signs a License Agreement with Mesoblast to Develop and

Tuba Khan November 20, 2020

Shots: Mesoblast to receive $25M up front and $25M as equity investment with additional payments and royalties on achievement of development, regulatory and commercial milestones Novartis to acquire the exclusive WW rights to develop, commercialize & manufacture remestemcel-L for ARDS & access to a cell-therapy based platform with WW rights to a range of potential […]Read More

COVID-19

PharmaShots: COVID-19 Healthcare News Monthly Updates – June 2020

Tuba Khan June 30, 2020

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019. PharmaShots is keeping a track of all of the important updates in the Lifesciences sector, where […]Read More

Insights+

Insights+: COVID-19 Healthcare News Monthly Updates – May 2020

Tuba Khan May 29, 2020

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019 PharmaShots is keeping a track of all of the important updates in the Lifesciences sector, where […]Read More

Takeda Signs an Exclusive License Agreement with Ovid for Soticlestat to Treat Dravet Syndrome and Lennox-Gastaut Syndrome

G1 Therapeutics and Boehringer Ingelheim Launch Cosela (trilaciclib) in the US

Lilly Collaborates with Biolojic to Discover and Develop Antibody Therapies for Diabetes

Sanofi Collaborates with Sirion to Develop Gene Therapy Treatment with Improved AAV Capsids

Alteogen Reports Completion of P-I Study of ALT-L9 (biosimilar, aflibercept) in Korea

Biocon Biologics and Viatris Receive CHMP’s Positive Opinion for Abevmy (biosimilar, bevacizumab)

Takeda Reports NDA Submission to Import and Distribute Moderna’s mRNA-1273 in Japan

Regeneron’s Ab Cocktail (casirivimab + imdevimab) Receives the CHMP’s Positive Opinion to Treat COVID-19

Kite’s Yescarta Receives the US FDA’s Approval for R/R Follicular Lymphoma

Roche to Withdraw Tecentriq Indication in Metastatic Bladder Cancer in the US

Atea Presents Results of AT-527 in P-I Study for COVID 19 at CROI

Gilead Presents Four-Year Data of Biktarvy for HIV-1 in Treatment-Naïve Adults at CROI 2021

Tags : Mesoblast

PharmaShots Weekly Snapshot (Nov 16-20, 2020)

Novartis Signs a License Agreement with Mesoblast to Develop and

PharmaShots: COVID-19 Healthcare News Monthly Updates – June 2020

Insights+: COVID-19 Healthcare News Monthly Updates – May 2020

Latest Posts

Lilly Collaborates with Biolojic to Discover and Develop Antibody Therapies for Diabetes

Alteogen Reports Completion of P-I Study of ALT-L9 (biosimilar, aflibercept) in Korea

ViewPoints Interview: ProQR’s Daniel A. de Boer Shares Insight on Sepofarsen, the First Treatment for Leber Congenital Amaurosis 10 (LCA10)

Atea Presents Results of AT-527 in P-I Study for COVID 19 at CROI

Tags : Mesoblast

Latest Posts

Categories

Related Topics